Chelerythrine chloride

貨號 Cat. No.
C-400
規格 Size
10 x 0.25 mg 1mg 5x1mg 5mg

Description

Chelerythrine chloride


Protein Kinase C Inhibitor











Product#: C-400

























Sizes:
10 x 0.25 mg
1 mg
5 x 1 mg
5 mg
 
 














M.W.: 383.84










CAS No.:

[3895-92-9]














Structure:
.








 










Purity: >99%












Bioassay:

The biological activity was tested to confirm the ability of Chelerythrine to inhibit PKC.













NIH/3T3 cells were incubated with different concentrations of Chelerythrine (0-20 mM) for 30 min and then stimulated with TPA (3ng/ml) for 20 min. Cell extracts were blotted and probed with Phospho-Myristoylated alanin-rich protein kinase C substrate (P-MARCKS) antibody.









 









References:


































1.



Herbert, J.M. et al. (1990) Biochem. Biophys. Res. Commun. 172, 993.



2.


Chao, M.D. et al. (1998) Planta Med. 64, 662.

3.


Ko, F.N. et al. (1990) Biochim. Biophys. Acta 1052, 360.

4.


Le Corvoisier, P. et al. (2002) Fundam. Clin. Pharmacol. 16, 31.

5.


Shi, L. et al. (1999) Arch. Biochem. Biophys. 368, 40.

6.


Sweeney, J.F. et al. (2000) Shock 13, 464.

7.



Chan, S.L. et al. (2003) J Biol. Chem. 278, 20453.




Chelerythrine is a potent, cell-permeable inhibitor of protein kinase C (IC50 = 660nM) that binds to the catalytic domain of PKC. Chelerythrine is at least 100-fold more selective for PKCs than for other kinases.1,2 


In platelets, Chelerythrine inhibits thromboxane formation and phosphoinositide metabolism.3,4 It has an inhibitory effect on ACh-induced current in PC12 cells.5

Chelerythrine induces apoptotic cell death in polymorphonuclear leukocyte through activation of caspase-3.6 Furthermore, Chelerythrine treated cells underwent apoptosis, with features that suggest involvement of the mitochondrial pathway, and through a mechanism that involves inhibition of the anti-apoptotic inhibitor BclXL.7


 


詢價 / 洽詢此產品

回到產品列表

▲ LINE
諮詢